Status:
COMPLETED
Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Estimate, With the Contribution of Optimized MRI, the Prevalence of Neurological and Neurovascular Manifestations on Imaging in the Event of SARS-CoV-2
Eligibility:
All Genders
18+ years
Brief Summary
When patients arrive in the waiting room of the MRI department, patients will be given the briefing note explaining the purpose of the study and how it is going. During the consultation, the radiologi...
Eligibility Criteria
Inclusion
- Patient\> 18 years old Express consent to participate in the study Affiliate or beneficiary of a social security scheme Patient with suspected SARS-CoV-2 infection in an epidemic context, confirmed or not by PCR, or close contact with a case confirmed by PCR, typical chest scanner (non-systematized frosted glass areas predominantly sub-pleural, and at a later stage of alveolar condensation without excavations, nodules or masses) or positive serology; Patient to benefit from a brain MRI for an indication within the scope of care
Exclusion
- Patient benefiting from a legal protection measure Pregnant or breastfeeding woman
Key Trial Info
Start Date :
May 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 19 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04448054
Start Date
May 20 2020
End Date
December 19 2023
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation A De Rothschild
Paris, France, 75019